HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
1) 194 - 5-HT3 Receptor Antagonists for Nausea/Vomiting: An In-Depth Drug Class Review
In this episode, we review the pharmacology, indications, adverse effects, and unique drug characteristics of 5-HT3 receptor antagonists such as ondansetron (Zofran) and palonosetron (Aloxi). Key Conc...Show More
2) 193 - Elevate Your Guideline Knowledge, Not Your BP: The New 2025 Hypertension Guidelines
In this episode, we review the newly published 2025 ACC/AHA hypertension guidelines. Key Concepts Instead of the Pooled Cohort Equations (PCE) from 2013, the 2025 hypertension guidelines recommend a ...Show More
3) 192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative
In this episode, we discuss the evidence, safety, and place in therapy of Journavx® (suzetrigine), a newly approved analgesic with a unique non-opioid mechanism of action and additional considerations...Show More
192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative
33:57 | Jul 23rd, 2025
4) 191 - The Ultimate Guide to ARBs: An In-depth Drug Class Review
In this episode, we review the pharmacology, indications, adverse effects, monitoring, and unique drug characteristics of angiotensin receptor blockers (ARBs). Key Concepts ARBs are equally efficaci...Show More
5) 190 - Can’t Stop, Won’t Drop … The BP That Just Won’t Quit: Diagnosis and Treatment of Resistant Hypertension
In this episode, we discuss the diagnosis and treatment of resistant hypertension, including a newer endothelin receptor antagonist (ERA) called aprocitentan (Tryvio®). Key Concepts The diagnosis of ...Show More
6) 189 - Mice, Macrophages, and Metabolism: Browning Keeps Obesity at Bay
In this episode, we discuss the very early stages of drug targets and drug development with Dr. Mohd Shahid, PhD. Dr. Shahid’s research involves the IER3 gene, which is an important modulator of the b...Show More
7) 188 - The Clot Thickens: Key Updates from the 2025 Acute Coronary Syndromes Guidelines
In this episode, we review the new 2025 ACC/AHA Acute Coronary Syndrome (ACS) guidelines, with a particular focus on guideline recommendations for analgesics, P2Y12 inhibitors, parenteral anticoagulat...Show More
8) 187 - Infectious Ambitions: A Pharmacist's Career Pivot from Clinical to Industry
In this episode, we interview Morgan Anderson, PharmD, BCIDP, a graduate of the RFUMS College of Pharmacy, about her career path from a pharmacy resident, emergency medicine specialist, infectious dis...Show More
187 - Infectious Ambitions: A Pharmacist's Career Pivot from Clinical to Industry
39:48 | Jan 23rd, 2025
9) 186 - Breaking the Bank or Breaking the Scale: Controversies Surrounding Compounded GLP-1s RAs for Weight Loss
In this episode, we discuss the efficacy and safety of semaglutide and tirzepatide for weight loss with a particular focus on the legal, regulatory, and safety aspects of these “compounded” GLP-1 rece...Show More
10) 185 - They Are Late, but Don’t Stress: The New 2024 Stress Ulcer Prophylaxis Guidelines
In this episode, we review the recommendations from the 2024 SCCM/ASHP stress ulcer prophylaxis guidelines and highlight three of the more recent landmark critical care trials investigating the role o...Show More